TY  - GEN
AU  - Lee,Jung-Hee
AU  - Lee,Je-Hwan
AU  - Kim,Dae-Young
AU  - Seol,Miee
AU  - Lee,Young-Shin
AU  - Kang,Young-Ah
AU  - Jeon,Mijin
AU  - Lee,Kyoo-Hyung
TI  - A Phase II Trial of Fludarabine/Melphalan 100 Conditioning Therapy Followed by Allogeneic Hematopoietic Cell Transplantation for Patients With Lymphoma
SN  - 2152-2669
PY  - 2016///0909
KW  - Adolescent
KW  - Adult
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Female
KW  - Graft Survival
KW  - Graft vs Host Disease
KW  - etiology
KW  - Hematopoietic Stem Cell Transplantation
KW  - adverse effects
KW  - Humans
KW  - Lymphoma
KW  - diagnosis
KW  - Male
KW  - Melphalan
KW  - administration & dosage
KW  - Middle Aged
KW  - Prognosis
KW  - Transplantation Conditioning
KW  - Transplantation, Homologous
KW  - Treatment Outcome
KW  - Vidarabine
KW  - Young Adult
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.clml.2015.08.087
ER  -